Development and Validation of an Early Mortality Risk Score for Older Patients Treated with Chemotherapy for Cancer


Por: Feliu J, Pinto A, Basterretxea L, López-San Vicente B, Paredero I, Llabrés E, Jiménez-Munárriz B, Antonio-Rebollo M, Losada B, Espinosa E, Gironés R, Custodio AB, Muñoz MDM, Díaz-Almirón M, Gómez-Mediavilla J, Torregrosa MD, Soler G, Cruz P, Higuera O, González-Montalvo JI and Molina-Garrido MJ

Publicada: 1 abr 2021 Ahead of Print: 10 abr 2021
Categoría: Medicine (miscellaneous)

Resumen:
Background: Estimation of life expectancy in older patients is relevant to select the best treatment strategy. We aimed to develop and validate a score to predict early mortality in older patients with cancer. Patients and Methods: A total of 749 patients over 70 years starting new chemotherapy regimens were prospectively included. A prechemotherapy assessment that included sociodemographic variables, tumor/treatment variables, and geriatric assessment variables was performed. Association between these factors and early death was examined using multivariable logistic regression. Score points were assigned to each risk factor. External validation was performed on an independent cohort. Results: In the training cohort, the independent predictors of 6-month mortality were metastatic stage (OR 4.8, 95% CI [2.4-9.6]), ECOG-PS 2 (OR 2.3, 95% CI [1.1-5.2]), ADL <= 5 (OR 1.7, 95% CI [1.1-3.5]), serum albumin levels <= 3.5 g/dL (OR 3.4, 95% CI [1.7-6.6]), BMI < 23 kg/m(2) (OR 2.5, 95% CI [1.3-4.9]), and hemoglobin levels < 11 g/dL (OR 2.4, 95% CI (1.2-4.7)). With these results, we built a prognostic score. The area under the ROC curve was 0.78 (95% CI, 0.73 to 0.84), and in the validation set, it was 0.73 (95% CI: 0.67-0.79). Conclusions: This simple and highly accurate tool can help physicians making decisions in elderly patients with cancer who are planned to initiate chemotherapy treatment.

Filiaciones:
Feliu J:
 Oncology Department, Hospital Universitario La Paz, IDIPAZ, Cátedra UAM-AMGEN, CIBERONC, 28046 Madrid, Spain

Pinto A:
 Oncology Department, Hospital Universitario La Paz, IDIPAZ, Cátedra UAM-AMGEN, CIBERONC, 28046 Madrid, Spain

Basterretxea L:
 Oncology Department, OSI Donostialde, Donostia Unibertsitate Ospitalea, Donostialde, Donostia, 20014 Gipuzkoa, Spain

López-San Vicente B:
 Oncology Department, OSI Bilbao, 48013 Bilbao, Spain

:
 Oncology Department, Hospital Universitario Dr. Peset, 46017 Valencia, Spain

Llabrés E:
 Oncology Department, Hospital Universitario Insular de Gran Canarias, 35016 Las Palmas, Spain

Jiménez-Munárriz B:
 Oncology Department, Centro Integral Oncológico Clara Campal, 28050 Madrid, Spain

Antonio-Rebollo M:
 Oncohematogeriatrics Unit, Institut Català d'Oncologia, IDIBELL, Hospitalet, 08908 Barcelona, Spain

Losada B:
 Oncology Department, Hospital Universitario de Fuenlabrada, 28942 Fuenlabrada, Spain

Espinosa E:
 Oncology Department, Hospital Universitario La Paz, IDIPAZ, Cátedra UAM-AMGEN, CIBERONC, 28046 Madrid, Spain

Gironés R:
 Oncology Department, Hospital Universitari y Politécnic La Fé, 46026 Valencia, Spain

Custodio AB:
 Oncology Department, Hospital Universitario La Paz, IDIPAZ, Cátedra UAM-AMGEN, CIBERONC, 28046 Madrid, Spain

Muñoz MDM:
 Oncology Department, Hospital Virgen de la Luz, 16002 Cuenca, Spain

Díaz-Almirón M:
 Biostatistics Department, Hospital La Paz, Universidad Autónoma de Madrid, 28046 Madrid, Spain

Gómez-Mediavilla J:
 Oncology Department, OSI Donostialde, Donostia Unibertsitate Ospitalea, Donostialde, Donostia, 20014 Gipuzkoa, Spain

:
 Oncology Department, Hospital Universitario Dr. Peset, 46017 Valencia, Spain

Soler G:
 Oncohematogeriatrics Unit, Institut Català d'Oncologia, IDIBELL, Hospitalet, 08908 Barcelona, Spain

Cruz P:
 Oncology Department, Hospital Universitario La Paz, IDIPAZ, Cátedra UAM-AMGEN, CIBERONC, 28046 Madrid, Spain

Higuera O:
 Oncology Department, Hospital Universitario La Paz, IDIPAZ, Cátedra UAM-AMGEN, CIBERONC, 28046 Madrid, Spain

González-Montalvo JI:
 Geriatric Department, Hospital Universitario La Paz, IDIPAZ, 28046 Madrid, Spain

Molina-Garrido MJ:
 Oncology Department, Hospital Virgen de la Luz, 16002 Cuenca, Spain
ISSN: 20770383





Journal of Clinical Medicine
Editorial
MDPI, ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 10 Número: 8
Páginas:
WOS Id: 000644479400001
ID de PubMed: 33920250
imagen Green Published, gold

FULL TEXT

imagen Published Version CC BY 4.0

MÉTRICAS